These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18976257)

  • 1. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study.
    López-Jornet P; Camacho-Alonso F; Leon-Espinosa S
    J Oral Rehabil; 2009 Jan; 36(1):52-7. PubMed ID: 18976257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study.
    Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S
    Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies.
    Femiano F
    Minerva Stomatol; 2002 Sep; 51(9):405-9. PubMed ID: 12473978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burning mouth syndrome: the efficacy of lipoic acid on subgroups.
    Femiano F; Gombos F; Scully C
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):676-8. PubMed ID: 15482293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial.
    Cavalcanti DR; da Silveira FR
    J Oral Pathol Med; 2009 Mar; 38(3):254-61. PubMed ID: 19175713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth.
    Steele JC; Bruce AJ; Drage LA; Rogers RS
    Oral Dis; 2008 Sep; 14(6):529-32. PubMed ID: 18266840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy.
    Femiano F; Gombos F; Scully C
    Med Oral; 2004; 9(1):8-13. PubMed ID: 14704612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trazodone in burning mouth pain: a placebo-controlled, double-blind study.
    Tammiala-Salonen T; Forssell H
    J Orofac Pain; 1999; 13(2):83-8. PubMed ID: 10425979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Burning mouth syndrome and alpha-lipoic acid].
    Cervigón González I; Torres LM; Palomo A
    Actas Dermosifiliogr; 2009 Mar; 100(2):154-5. PubMed ID: 19445885
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial.
    Palacios-Sánchez B; Moreno-López LA; Cerero-Lapiedra R; Llamas-Martínez S; Esparza-Gómez G
    Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e435-40. PubMed ID: 26034927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology.
    Femiano F; Gombos F; Scully C; Busciolano M; De Luca P
    Oral Dis; 2000 Sep; 6(5):274-7. PubMed ID: 11002408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary protocol for systemic administration of capsaicin for the treatment of the burning mouth syndrome].
    Lauritano D; Petruzzi M; Baldoni M
    Minerva Stomatol; 2003 Jun; 52(6):273-8. PubMed ID: 12874531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature.
    de Moraes M; do Amaral Bezerra BA; da Rocha Neto PC; de Oliveira Soares AC; Pinto LP; de Lisboa Lopes Costa A
    J Oral Pathol Med; 2012 Apr; 41(4):281-7. PubMed ID: 22092585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.
    Femiano F; Scully C
    J Oral Pathol Med; 2002 May; 31(5):267-9. PubMed ID: 12110042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?
    Gianturco V; Bellomo A; D'Ottavio E; Formosa V; Iori A; Mancinella M; Troisi G; Marigliano V
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():129-33. PubMed ID: 19836626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of moclobemide in burning mouth syndrome: a nonrandomized, open-label study.
    Pekiner FN; Gumru B; Ozbayrak S
    J Orofac Pain; 2008; 22(2):146-52. PubMed ID: 18548844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of laser therapy and alpha-lipoic acid for the treatment of burning mouth syndrome: a randomized clinical trial.
    Barbosa NG; Gonzaga AKG; de Sena Fernandes LL; da Fonseca AG; Queiroz SIML; Lemos TMAM; da Silveira ÉJD; de Medeiros AMC
    Lasers Med Sci; 2018 Aug; 33(6):1255-1262. PubMed ID: 29502160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.